| Old Articles: <Older 42871-42880 Newer> |
|---|
 |
The Motley Fool
August 5, 2010
Anders Bylund |
Where Did This 19% Jump Come From? Atmel's turnaround is headed for a happy ending.   |
The Motley Fool
August 5, 2010
Seth Jayson |
Show Me the Money, Alcon With questionable cash sources comprising 4% of the cash flow from operations for Alcon, I am pretty confident things are OK. |
The Motley Fool
August 5, 2010
David Lee Smith |
Dow Chemical Appears to Be Cured With outages completed, and revenue climbing, Dow Chemical should be coming back. |
The Motley Fool
August 5, 2010
Jason Moser |
My Big Fat Greek Shipping Stock Three dry bulk shipping stocks based out of Greece for your consideration. |
The Motley Fool
August 5, 2010
Tim Hanson |
Why MercadoLibre Can't Keep Rising There's a hard limit to the auction site's future growth. |
The Motley Fool
August 5, 2010
Rich Smith |
Look, Up in the Air! Is it a bird? Is it a robot? Heck no! It's a manned fighter jet. Admiral Michael Mullen may believe there's no need for pilots in planes anymore, but some of the biggest names in unmanned-aerial-vehicle building are begging to differ. |
The Motley Fool
August 5, 2010
Mac Greer |
Sirius XM Earnings Roundtable: Revving Up? Two analysts are bullish on Sirius XM after the company released its earnings report. |
The Motley Fool
August 5, 2010
Eric Wesoff |
Can a Disruptive PV Technology Topple First Solar? We list a few candidates for a "new black swan improbable pyro-nano-quantum-thingamajig technology" to displace thin-film PV. |
The Motley Fool
August 5, 2010
Alyce Lomax |
Starbucks' Secret Weapon It's, uh, actually not so secret anymore. |
The Motley Fool
August 5, 2010
Brian Orelli |
Blockbuster Efficacy! Not-So-Blockbuster Safety! Isis and Genzyme's wonder drug has not-so-wonderful side effects. Still. |
| <Older 42871-42880 Newer> Return to current articles. |
